Newberg, Ore. (March 12, 2021) – To help patients who have substance use disorders find quality on-site and virtual treatment services, Regence BlueCross BlueShield of Oregon has recognized two Hazelden Betty Ford Foundation sites in Oregon as Blue Distinction® Centers for Substance Use Treatment and Recovery. Hazelden Betty Ford's facilities in Newberg and Beaverton—which provide care on-site and to Oregonians anywhere via telehealth—are among the first to receive the new designation under the Blue Distinction Specialty Care program.
Blue Distinction Centers are nationally designated facilities that show a commitment to delivering improved patient safety and better health outcomes, based on objective measures that were developed with input from the community and leading accreditation and quality organizations.
According to the Centers for Disease Control and Prevention, 130 Americans die every day from an opioid overdose, which highlights the seriousness of the opioid epidemic and how critical it is for patients to receive comprehensive, meaningful care. The Blue Distinction Center for Substance Use Treatment and Recovery program requires designated facilities to deliver coordinated multidisciplinary care to patients and provide timely access to quality medical and psychosocial care in all phases of treatment. Designated facilities must also offer medication-assisted treatment—an approach to treating opioid addiction that includes both medications and evidence-based psychosocial therapies.
"We are extremely excited and grateful that the Blue Cross Blue Shield Association recognizes the importance of adding substance use disorder as the 11th disease category in its Blue Distinction Specialty Care program. This is huge in so many ways—a sign that addiction treatment has come of age within mainstream health care," said Bob Poznanovich, vice president of business development at Hazelden Betty Ford.
"Regence's leadership in vetting addiction treatment providers for quality, evidence-based care and promoting to consumers those with the best demonstrated outcomes will smash historical stigmas, incentivize quality, and protect consumers by providing them with in-network options they can trust," Poznanovich added. "No one will benefit more from the centers-of-excellence strategy that is growing within health care than the millions of Americans who are facing addiction-related challenges at home or in the workplace. We are proud and thankful to be recognized by Regence and to be part of mainstreaming addiction care so that more individuals and families are able to get the help they need."
"Recognizing Hazelden Betty Ford's Oregon facilities as Blue Distinction Centers speaks to the provider's high-quality care for substance use and recovery care," said Dr. Hossam Mahmoud, Regence's behavioral health medical director. "Health plans and providers must work together to continue raising awareness and ensuring people and families dealing with addiction receive the care and support they need."
Since 2006, the Blue Distinction Specialty Care program has helped patients find quality specialty care in the areas of bariatric surgery, cancer care, cardiac care, cellular immunotherapy, fertility care, gene therapy, knee and hip replacements, maternity care, spine surgery, substance use treatment and recovery, and transplants, while encouraging health care professionals to improve the care they deliver. Research for many programs shows that, compared to other providers, those designated as Blue Distinction Centers demonstrate better quality and improved outcomes for patients.
For more information about the program and for a complete listing of the designated facilities, visit www.bcbs.com/bluedistinction.
Regence BlueCross BlueShield of Oregon, headquartered in Portland, has been serving Oregonians since 1941 and now provides more than 974,000 people with comprehensive health insurance solutions. As a nonprofit independent licensee of the Blue Cross and Blue Shield Association, Regence is part of a family of companies dedicated to transforming health care by delivering innovative products and services that change the way consumers nationwide experience health care. For more information, please visit regence.com, facebook.com/regencebluecrossblueshield, or twitter.com/regenceoregon.
Blue Distinction Centers (BDC) met overall quality measures, developed with input from the medical community. A Local Blue Plan may require additional criteria for providers located in its own service area; for details, contact your Local Blue Plan. Blue Distinction Centers+ (BDC+) also met cost measures that address consumers' need for affordable healthcare. Each provider's cost of care is evaluated using data from its Local Blue Plan. Providers in CA, ID, NY, PA, and WA may lie in two Local Blue Plans' areas, resulting in two evaluations for cost of care; and their own Local Blue Plans decide whether one or both cost of care evaluation(s) must meet BDC+ national criteria. National criteria for BDC and BDC+ are displayed on www.bcbs.com. Individual outcomes may vary. For details on a provider's in-network status or your own policy's coverage, contact your Local Blue Plan and ask your provider before making an appointment. Neither Blue Cross and Blue Shield Association nor any Blue Plans are responsible for non-covered charges or other losses or damages resulting from Blue Distinction or other provider finder information or care received from Blue Distinction or other providers.
The Hazelden Betty Ford Foundation is a force of healing and hope for individuals, families and communities affected by addiction to alcohol and other drugs. As the nation's leading nonprofit provider of comprehensive inpatient and outpatient addiction and mental health care for adults and youth, the Foundation has treatment centers and telehealth services nationwide as well as a network of collaborators throughout health care. Through charitable support and a commitment to innovation, the Foundation is able to continually enhance care, research, programs and services, and help more people. With a legacy that began in 1949 and includes the 1982 founding of the Betty Ford Center, the Foundation today is committed to diversity, equity and inclusion in its services and throughout the organization, which also encompasses a graduate school of addiction studies, a publishing division, an addiction research center, recovery advocacy and thought leadership, professional and medical education programs, school-based prevention resources and a specialized program for children who grow up in families with addiction. Learn more at HazeldenBettyFord.org and on Twitter.